Comparison between Channel Nine Entertainment IPO and HPC Biosciences IPO.
Channel Nine Entertainment IPO is a SME Fixed Price IPO proposed to list at BSE SME while HPC Biosciences IPO is a SME Fixed Price proposed to list at BSE SME.
| Channel Nine Entertainment IPO | HPC Biosciences IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Oneview Corporate Advisors Pvt.Ltd. | Oneview Corporate Advisors Pvt.Ltd. |
| Registrar | Beetal Financial & Computer Services Pvt.Ltd. | Cameo Corporate Services Ltd. |
| Market Maker | Narayan Securities Ltd. | Narayan Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Channel Nine Entertainment IPO is up to ₹11.12 Cr whereas the issue size of the HPC Biosciences IPO is up to ₹15.15 Cr. The final issue price of Channel Nine Entertainment IPO is ₹25.00 per share and of HPC Biosciences IPO is ₹35.00 per share.
| Channel Nine Entertainment IPO | HPC Biosciences IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹25.00 per share | ₹35.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 6000 shares | 4000 shares |
| Fresh Issue Size | 44,46,000 shares | 43,28,000 shares |
| Fresh Issue Size (Amount) | up to ₹11.12 Cr | up to ₹15.15 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 44,46,000 shares | 43,28,000 shares |
| Issue Size Total (Amount) | up to ₹11.12 Cr | up to ₹15.15 Cr |
Channel Nine Entertainment IPO opens on Feb 22, 2013, while HPC Biosciences IPO opens on Mar 01, 2013. The closing date of Channel Nine Entertainment IPO and HPC Biosciences IPO is Feb 26, 2013, and Mar 05, 2013, respectively.
| Channel Nine Entertainment IPO | HPC Biosciences IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Feb 22, 2013 | Mar 01, 2013 |
| Issue Close | Feb 26, 2013 | Mar 05, 2013 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Mar 12, 2013 | Mar 19, 2013 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Channel Nine Entertainment IPO P/E ratio is , as compared to HPC Biosciences IPO P/E ratio of .
| Channel Nine Entertainment IPO | HPC Biosciences IPO | |
|---|---|---|
| Financials | ||
| Promoter Shareholding (Pre-Issue) | 29.48 | 30.69 |
| Promoter Shareholding (Post-Issue) | 20.6 | 22.01 |
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW | 1.33% | 63.53% |
In the Channel Nine Entertainment IPO Retail Individual Investors (RII) are offered 22,14,000 shares while in HPC Biosciences IPO retail investors are offered 22,14,000 shares. Qualified Institutional Buyers (QIB) are offered in Channel Nine Entertainment IPO and in HPC Biosciences IPO.
| Channel Nine Entertainment IPO | HPC Biosciences IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 2,40,000 shares | 2,32,000 shares |
| QIB | ||
| NII | 22,14,000 shares | 21,34,000 shares |
| RII | 22,14,000 shares | 21,34,000 shares |
| Employee | ||
| Others | ||
| Total | 44,28,000 shares | 42,68,000 shares |
Channel Nine Entertainment IPO subscribed in total, whereas HPC Biosciences IPO subscribed .
| Channel Nine Entertainment IPO | HPC Biosciences IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
